Josée Bouchard1, Anjali Acharya2, Jorge Cerda3, Elizabeth R Maccariello4, Rajasekara Chakravarthi Madarasu5, Ashita J Tolwani6, Xinling Liang7, Ping Fu8, Zhi-Hong Liu9, Ravindra L Mehta10. 1. Department of Medicine, University of Montreal, Montréal, Québec, Canada; 2. Department of Medicine, Jacobi Medical Center, New York, New York; 3. Albany Medical College, Albany, New York; 4. Department of Medicine, Quinta D'Or Hospital, Rio de Janeiro, Brazil; 5. Department of Medicine, CARE Hospitals, Banjara Hills, Hyderabad, India; 6. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; 7. Department of Medicine, Guangdong General Hospital, Guangzhou, China; 8. Department of Medicine, West China School of Medicine Sichuan University, Chengdu, Sichuan, China; 9. Department of Medicine, Jinling Hospital, Nanjing University, Nanjing, China; and. 10. Department of Medicine, University of California at San Diego, San Diego, California rmehta@ucsd.edu.
Abstract
BACKGROUND AND OBJECTIVES: AKI is frequent and is associated with poor outcomes. There is limited information on the epidemiology of AKI worldwide. This study compared patients with AKI in emerging and developed countries to determine the association of clinical factors and processes of care with outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective observational study was conducted among intensive care unit patients from nine centers in developed countries and five centers in emerging countries. AKI was defined as an increase in creatinine of ≥0.3 mg/dl within 48 hours. RESULTS: Between 2008 and 2012, 6647 patients were screened, of whom 1275 (19.2%) developed AKI. A total of 745 (58% of those with AKI) agreed to participate and had complete data. Patients in developed countries had more sepsis (52.1% versus 38.0%) and higher Acute Physiology and Chronic Health Evaluation (APACHE) scores (mean±SD, 61.1±27.5 versus 51.1±25.2); those from emerging countries had more CKD (54.3% versus 38.3%), GN (6.3% versus 0.9%), and interstitial nephritis (7.0% versus 0.6%) (all P<0.05). Patients from developed countries were less often treated with dialysis (15.5% versus 30.2%; P<0.001) and started dialysis later after AKI diagnosis (2.0 [interquartile range, 0.75-5.0] days versus 0 [interquartile range, 0-5.0] days; P=0.02). Hospital mortality was 22.0%, and 13.3% of survivors were dialysis dependent at discharge. Independent risk factors associated with hospital mortality included older age, residence in an emerging country, use of vasopressors (emerging countries only), dialysis and mechanical ventilation, and higher APACHE score and cumulative fluid balance (developed countries only). A lower probability of renal recovery was associated with residence in an emerging country, higher APACHE score (emerging countries only) and dialysis, while mechanical ventilation was associated with renal recovery (developed countries only). CONCLUSIONS: This study contrasts the clinical features and management of AKI and demonstrates worse outcomes in emerging than in developed countries. Differences in variations in care may explain these findings and should be considered in future trials.
BACKGROUND AND OBJECTIVES: AKI is frequent and is associated with poor outcomes. There is limited information on the epidemiology of AKI worldwide. This study compared patients with AKI in emerging and developed countries to determine the association of clinical factors and processes of care with outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective observational study was conducted among intensive care unit patients from nine centers in developed countries and five centers in emerging countries. AKI was defined as an increase in creatinine of ≥0.3 mg/dl within 48 hours. RESULTS: Between 2008 and 2012, 6647 patients were screened, of whom 1275 (19.2%) developed AKI. A total of 745 (58% of those with AKI) agreed to participate and had complete data. Patients in developed countries had more sepsis (52.1% versus 38.0%) and higher Acute Physiology and Chronic Health Evaluation (APACHE) scores (mean±SD, 61.1±27.5 versus 51.1±25.2); those from emerging countries had more CKD (54.3% versus 38.3%), GN (6.3% versus 0.9%), and interstitial nephritis (7.0% versus 0.6%) (all P<0.05). Patients from developed countries were less often treated with dialysis (15.5% versus 30.2%; P<0.001) and started dialysis later after AKI diagnosis (2.0 [interquartile range, 0.75-5.0] days versus 0 [interquartile range, 0-5.0] days; P=0.02). Hospital mortality was 22.0%, and 13.3% of survivors were dialysis dependent at discharge. Independent risk factors associated with hospital mortality included older age, residence in an emerging country, use of vasopressors (emerging countries only), dialysis and mechanical ventilation, and higher APACHE score and cumulative fluid balance (developed countries only). A lower probability of renal recovery was associated with residence in an emerging country, higher APACHE score (emerging countries only) and dialysis, while mechanical ventilation was associated with renal recovery (developed countries only). CONCLUSIONS: This study contrasts the clinical features and management of AKI and demonstrates worse outcomes in emerging than in developed countries. Differences in variations in care may explain these findings and should be considered in future trials.
Authors: Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin Journal: N Engl J Med Date: 2006-05-21 Impact factor: 91.245
Authors: A de Mendonça; J L Vincent; P M Suter; R Moreno; N M Dearden; M Antonelli; J Takala; C Sprung; F Cantraine Journal: Intensive Care Med Date: 2000-07 Impact factor: 17.440
Authors: Philipp G H Metnitz; Claus G Krenn; Heinz Steltzer; Thomas Lang; Jürgen Ploder; Kurt Lenz; Jean-Roger Le Gall; Wilfred Druml Journal: Crit Care Med Date: 2002-09 Impact factor: 7.598
Authors: Pierre-Marc Villeneuve; Edward G Clark; Lindsey Sikora; Manish M Sood; Sean M Bagshaw Journal: Intensive Care Med Date: 2015-12-01 Impact factor: 17.440
Authors: Philippe Lachance; Pierre-Marc Villeneuve; Oleksa G Rewa; Francis P Wilson; Nicholas M Selby; Robin M Featherstone; Sean M Bagshaw Journal: Nephrol Dial Transplant Date: 2017-02-01 Impact factor: 5.992
Authors: Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum Journal: Kidney Int Date: 2019-06-07 Impact factor: 10.612
Authors: Rinaldo Bellomo; John A Kellum; Claudio Ronco; Ron Wald; Johan Martensson; Matthew Maiden; Sean M Bagshaw; Neil J Glassford; Yugeesh Lankadeva; Suvi T Vaara; Antoine Schneider Journal: Intensive Care Med Date: 2017-03-31 Impact factor: 17.440
Authors: Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre Journal: Ann Intensive Care Date: 2017-05-04 Impact factor: 6.925
Authors: Natalja L Stanski; Erin K Stenson; Natalie Z Cvijanovich; Scott L Weiss; Julie C Fitzgerald; Michael T Bigham; Parag N Jain; Adam Schwarz; Riad Lutfi; Jeffrey Nowak; Geoffrey L Allen; Neal J Thomas; Jocelyn R Grunwell; Torrey Baines; Michael Quasney; Bereketeab Haileselassie; Hector R Wong Journal: Am J Respir Crit Care Med Date: 2020-04-01 Impact factor: 21.405